Oral Sessions
(Day1, Day2, Day3, Day4)
Poster Presentations
(Day1, Day2, Day3, Day4)
Luncheon Seminars
(Day1, Day2, Day3, Day4)
Oral Sessions Day 4, May 18(Fri.)
- The mark "☆" shows that the presenting author applied to the "Best Presentation Award".
-
[4A-O1-P] PTM proteomics & functional proteomics
Room A (OrBit Hall) 09:00-11:00
Chair: Jun Adachi (NIBIOHN) / Kazuishi Kubota (Daiichi Sankyo RD Novare)
-
4A-O1-P-0900 09:00-09:20
Global Identification and Functional Characterization of Protein Kinase Substrates using Various Phosphoproteomic Technologies
-
4A-O1-P-0920 09:20-09:40
Phosphorylation Network Analysis Based on Kinome Profiling
-
4A-O1-P-0940 09:40-10:00
Phosphoproteomics of non-small-cell lung cancer cells treated with erlotinib reveals drug-resistant signatures and potential targets
-
4A-O1-P-1000(2P-55) 10:00-10:20
☆An improved method for cell type-specific glycomic analysis of formalin-fixed paraffin-embedded tissue sections in combination with histochemical stainingAn improved method for cell type-specific glycomic analysis of formalin-fixed paraffin-embedded
-
4A-O1-P-1020 10:20-10:40
Selective Degradation of Splicing Factor CAPERα by Anticancer Sulfonamides
-
4A-O1-P-1040 10:40-11:00
Applications of proteomics for drug discovery and development
-
[4A-L-P] AOHUPO session 2 (Supported by Thermo Fisher Scientific K.K.)
Room A (OrBit Hall) 12:10-13:10
Chair: Yu-Ju Chen (Academia Sinica)
-
4A-L-P-1210 12:10-12:20
Introduction
-
4A-L-P-1220 12:20-12:40
High Efficient and Precise Glycoproteomic Analysis with Intelligent Technology
-
4A-L-P-1240 12:40-13:00
Development of salivary protein biomarkers for oral cancer
-
4A-L-P-1300 13:00-13:10
Development of ELISA assay by eiptope mapping of CagA protein recognized by antibodies in sear for the prevention of Japanese children from chronic infection of Helicobacter pylori
-
[4A-O2-P] What everyone ought to know about the recent progress and perspectives of disease proteomics
Room A (OrBit Hall) 14:25-16:25
Chair: Tadashi Kondo (National Cancer Center)
-
4A-O2-P-1425 14:25-15:05 [Keynote]
A Proteomic Landscape of Diffuse-type Gastric Cancer
-
4A-O2-P-1505 15:05-15:25
Systematic discovery of cancer biomarkers by integrative post-translational modification-directed proteomics
-
4A-O2-P-1525 15:25-15:45
Development of enzymomics approach to search for disease-related alternation of enzymatic functions
-
4A-O2-P-1545 15:45-16:05
A functional role of LEFTY as a molecular marker for ovarian clear cell carcinoma
-
4A-O2-P-1605 16:05-16:25
Proteogenomics for sarcoma research: International Cancer Proteogenomics Consortium (ICPC)
-
[4B-O1-P] JPrOS Young researchers in proteomics
Room B (Seiun 1) 09:00-11:00
Chair: Yuichi Abe (NIBIOHN)
-
4B-O1-P-0900(2P-56) 09:00-09:15
☆Comprehensive phosphoproteomics from biopsy specimens
-
4B-O1-P-0915(2P-57) 09:15-09:30
☆Establishment of method for peptidome analysis from a small amount of tissue
-
4B-O1-P-0930(2P-58) 09:30-09:45
☆Quantitative proteomic assessment of differences and stability of human serum and plasma proteins
-
4B-O1-P-0945(2P-59) 09:45-10:00
☆Development and application of strategy for comparative analysis of protein expression and functional state.
-
4B-O1-P-1000(2P-60) 10:00-10:15
☆Identification of internalized plasma membrane proteins in human brain capillary endothelial cells.
-
4B-O1-P-1015 10:15-10:30
Drought stress characterization of tolerant and sensitive barley genotypes through Proteomics analysis
-
4B-O1-P-1030(2P-61) 10:30-10:45
☆Comparative Phosphoproteomic Analysis of Fresh and After-ripened Barley seeds
-
4B-O1-P-1045 10:45-11:00
Soybean Proteomics: A Leading Tool in Exploring Effects of Flooding Stress using Proteomic Technique
-
[4B-O2-P] Cellular network analysis based on proteomics
Room B (Seiun 1) 14:25-16:25
Chair: Naoyuki Sugiyama (Kyoto Univ.) / Shinya Ohta (Kochi Univ.)
-
4B-O2-P-1425(2P-62) 14:25-14:45
☆Ribosomics reveals a novel mechanism for translational regulation
-
4B-O2-P-1445(4P-39) 14:45-15:05
☆TMT-based Quantitative Mass Spectrometry Reveals Proteomic Shifts between Traditional Hydrated Biofilm and DSB from Staphylococcus aureus: One Step Forward with Dry Surface Biofilm (DSB)
-
4B-O2-P-1505 15:05-15:25
Surface Proteome Profiles Meet Adipocyte Commitment
-
4B-O2-P-1525 15:25-15:45
Identification of pathogenic mutations in patients with rare diseases using multiomics approaches
-
4B-O2-P-1545 15:45-16:05
High-throughput biosynthesis of stable isotope-labeled internal standards for global proteome quantification
-
4B-O2-P-1605 16:05-16:25
Mass spectrometry-based proteogenomic analysis to identify novel protein-coding genes through the human proteome
-
[4C-O1-P] Role of mass spectrometry in the development and control of antibody drugs
Room C (Seiun 2) 09:00-11:00
Chair: Haruhiko Kamada (NIBIOHN) / Susumu Uchiyama (Osaka Univ.)
-
4C-O1-P-0900 09:00-09:20 [Invited]
In vitro Affinity Maturation of Catalytic Antibodies against Transition-state Analogues
-
4C-O1-P-0920 09:20-09:40
Target discovery method to stromal tissue for development of antibody drugs
-
4C-O1-P-0940 09:40-10:00
Characterization of the active catabolite formed in vivo from an Antibody Drug Conjugate with an Eg5 Inhibitor Payload and Stable Linker Design
-
4C-O1-P-1000 10:00-10:20
Evaluation of Chemical Stability of Therapeutic Antibodies using High-Resolution Mass Spectrometry
-
4C-O1-P-1020 10:20-10:40
Monitoring Multiple Critical Quality Attributes of mAbs at Subunit and Peptide Level Using a Compliant Ready High Resolution LC/MS Platform
-
4C-O1-P-1040 10:40-11:00
Characterization of Biopharmaceuticals: Development of Disulfide Linkage Analysis Method for Human Hepatocyte Growth Factor
-
[4C-O2-P] Mass spectrometry and omics research from information science
Room C (Seiun 2) 14:25-16:25
Chair: Shujiro Okuda (Niigata Univ.) / Akiyasu Yoshizawa (Kyoto Univ.)
-
4C-O2-P-1425 14:25-15:05 [Keynote]
Analysis of Measurement Data via Sparse Modeling
-
4C-O2-P-1505 15:05-15:25
Integrated characterisation of human cancer cell lines using public proteomics data
-
4C-O2-P-1525 15:25-15:45
Exploring the prostate and urinary glycoproteome for novel prostate cancer biomarkers
-
4C-O2-P-1545 15:45-16:05
When is a Biomarker not a biomarker? The problems of interpreting statistical data in Discovery ‘Omics analysis.
-
4C-O2-P-1605(4P-40) 16:05-16:25
☆Application of Non-negative Matrix Factorization in Mass Spectrometry-Based Shotgun Proteomics